Speaker:

It is my great pleasure now to introduce our chairman for today, Professor Sam Addy.

Speaker:

So Sam, or Professor Sam Addy, is a professor of orthopaedic and trauma surgery

Speaker:

at the University of New South Wales.

Speaker:

He specialises in surgery of the hip and knee, including primary and revision

Speaker:

surgeries of the, sorry, primary and

Speaker:

revision hip and knee replacement and arthroscopic surgery of the knee.

Speaker:

He completed his training in Sydney, followed by fellowship training at the

Speaker:

University of Oxford and the University of Toronto.

Speaker:

Professor Addy works at several hospitals across Sydney, including St George

Speaker:

Hospital, which is a Level 1 facility and one of the busiest referral centres in Australia.

Speaker:

He has been awarded approximately $15 million in competitive research grants.

Speaker:

And he has won numerous awards for his research and runs a series of clinical

Speaker:

trials to improve outcomes after joint replacement and injury.

Speaker:

And today Professor Addy will be speaking about hip arthritis in the young patient.

Speaker:

Thank you so much, Jody.

Speaker:

So this talk is about the young patient with arthritis.

Speaker:

There will be a talk a bit later, I think, by Munjid about hip problems in the older patient.

Speaker:

So I'm going to try and focus on issues specifically relating to young patients

Speaker:

who present with hip arthritis.

Speaker:

I mean, there's going to be a little bit of overlap between the two talks,

Speaker:

but hopefully some focus on issues specific to the young patient.

Speaker:

So this is my disclosure. I am a founding surgeon partner at the Orthopedic Institute here.

Speaker:

This is an outline of the talk today. So we're going to talk about the epidemiology of hip arthritis.

Speaker:

What causes it in the younger patient?

Speaker:

How do you assess and what's my decision-making sort of process when it comes

Speaker:

to the younger patient with hip arthritis?

Speaker:

Non-surgical treatments, surgical treatments, and then some questions.

Speaker:

All right. So when we're looking at epidemiology, osteoarthritis is still by

Speaker:

far the most common reason why a young patient will present with hip arthritis.

Speaker:

But it is a disease of age, right?

Speaker:

So the longer you live, the more likely it is that you will get an arthritis

Speaker:

of one joint or other. We all know that.

Speaker:

If you look at, there's going to be quite a lot of, I guess,

Speaker:

figures from the Australian Orthopedic Association joint replacement registry.

Speaker:

This is one of them. So if you look at, for example, the breakdown of age groups

Speaker:

for people having a hip replacement, which is essentially sort of the end result

Speaker:

of someone having severe arthritis,

Speaker:

you can see that the vast majority are in the older patient groups.

Speaker:

But there is a significant portion represented here by the green line of that

Speaker:

younger patient, the less than 55-year-old, who is having surgery for hip arthritis. Okay, so 15%.

Speaker:

The thing is with the younger patient is that there's a disproportionate effect on, I guess,

Speaker:

the life expectancy that they have and the number of years that they have to

Speaker:

live and the quality of life that I guess they have for the remainder of their life expectancy.

Speaker:

So you can see how there's a disproportionate effect in that younger patient age group.

Speaker:

And in fact I'd go further and say arthritis

Speaker:

as you know as a group of

Speaker:

disorders or musculoskeletal problems

Speaker:

is by far the most impactful problem

Speaker:

on our society generally when you're looking at sort of you know metrics like

Speaker:

quality of life years lost right so you know as a researcher all of the you

Speaker:

know the attention gets grabbed by cardiovascular disease and cancer and they

Speaker:

get the bulk of the funding all the time when we're competing for grants, right?

Speaker:

But if you look at the overall impact of these conditions, musculoskeletal problems,

Speaker:

when you're looking at low back pain, knee arthritis, hip arthritis,

Speaker:

by far the most impactful in terms of the number of quality life years lost.

Speaker:

And my point here specifically relating to the young patient is because of their

Speaker:

sort of the longer life expectancy, you're going to have a greater impact on them.

Speaker:

So what are the causes of hip arthritis in the younger patient?

Speaker:

Osteoarthritis is still the most common diagnosis.

Speaker:

And as we know, a lot of the time it is sort of idiopathic, but it's probably

Speaker:

related to people's genetics.

Speaker:

Obesity, there is some association with obesity and hip arthritis,

Speaker:

much more so with knee arthritis.

Speaker:

And I think Samir might be talking about knee arthritis a bit later,

Speaker:

but there is an association with hip arthritis as well.

Speaker:

Probably in association with some lifestyle factors like what sort of work you

Speaker:

do or what sports you do, probably related to some repetitive injuries that

Speaker:

you've had as a younger person, sports injuries that have just,

Speaker:

you know, just, you know, brewed and just gotten worse over time.

Speaker:

And then you get this sort of wear and tear appearance of the hip joint.

Speaker:

But there is a significant portion that are caused by these other things as well.

Speaker:

And I'm going to mention a few of them and maybe just show some images about what they look like.

Speaker:

So, Associate Professor Joshua has just talked about inflammatory arthritis,

Speaker:

definitely an important cause in the younger patient.

Speaker:

Because that inflammatory arthritis is, I guess, a different form of arthritis.

Speaker:

But the end result will be the degeneration of the cartilage and the wearing out of that joint.

Speaker:

And then you get sort of secondary osteoarthritis then

Speaker:

there's other reasons like avascular necrosis has

Speaker:

anyone here had a patient with avascular necrosis yeah

Speaker:

yeah it is it is pretty uncommon we see it disproportionately and we obviously

Speaker:

remember those patients because it is quite a devastating condition for that

Speaker:

younger patient where and i'll show you a picture of what it looks like later, but in our society,

Speaker:

alcoholism and the use of corticosteroids are by far the most common reasons why people get AVN.

Speaker:

But there's a whole laundry list of potential causes of AVN as well that you

Speaker:

can, you know, I remember reading them up as a med student, as a registrar and

Speaker:

sort of committing them to all memory, you know,

Speaker:

we use all of these mnemonics about how to memorize all of these things that caused AVN.

Speaker:

And occasionally you'd get someone who comes along and has one of these sort

Speaker:

of rarer conditions presenting with a case of AVN.

Speaker:

And then you have developmental problems. So if someone presents.

Speaker:

You know, a young patient presents with hip arthritis, one of the first questions

Speaker:

I ask is whether they had any hip problems as a child.

Speaker:

So these are things like developmental dysplasia or clicky hips,

Speaker:

you know, unstable hips as a kid, per-phase disease or slipped epiphyses.

Speaker:

The end result of all of those things is essentially

Speaker:

the patient is left with some sort of abnormal morphology

Speaker:

of their hip joint right so as we all know

Speaker:

the hip joint is essentially a ball and socket joint but

Speaker:

the further we deviate from that shape that simple

Speaker:

ball and socket shape the more likely it is that they're going to have I guess

Speaker:

overloading of certain parts of the hip and more likely it is that they'll present

Speaker:

earlier with arthritis and I guess there is an association with how bad that

Speaker:

dysmorphism is and how early they present.

Speaker:

So you can have someone who had a terrible condition as a kid and the hip is

Speaker:

like totally, you know, it's a totally abnormal shape, right?

Speaker:

But it doesn't mean that they get arthritis like immediately, okay?

Speaker:

So you can have like a square-shaped hip and that hip can sort of last for probably

Speaker:

about 20 or 30 years before they then present to you with symptoms of secondary

Speaker:

arthritis, secondary osteoarthritis, okay?

Speaker:

And then I've listed the femoracetabula impingement.

Speaker:

Has anyone here had a patient with FAI or impingement?

Speaker:

It's quite common and GPs are sort of, yeah, picking up on it much more so.

Speaker:

I've listed it there because we actually don't really know what causes that

Speaker:

abnormal shape with FAI, but we think it is probably a developmental problem

Speaker:

as well and I have a picture about what I mean later.

Speaker:

So this is AVN. This is an MRI of a patient with AVN.

Speaker:

And for one reason or another, essentially what you get is necrosis of this part of the bone.

Speaker:

In this case, quite a large portion of the femoral head is affected.

Speaker:

But it is an important part of the hip joint because it is that subchondral

Speaker:

bone that does a lot of the heavy lifting.

Speaker:

The cartilage itself isn't directly affected but

Speaker:

you can imagine when you have this part of the bone not being

Speaker:

very very healthy right essentially what

Speaker:

that leads to is the cartilage not being supported by that very very important

Speaker:

bone so in this case you've got someone with osteonecrosis of this section but

Speaker:

it hasn't collapsed yet so the next stage of this disease process is For parts

Speaker:

of that bone To just collapse under weight Or physiological.

Speaker:

Movements And then that cartilage then starts Also collapsing and then you get

Speaker:

again Secondary arthritis of that Joint,

Speaker:

So this is a very difficult problem To treat because this itself Is very very

Speaker:

painful Like that process of the patient having,

Speaker:

This bone sort of Slowly dying off Is a very very painful condition.

Speaker:

But the idea from my point of view, I mean, think of me as sort of like a mechanic.

Speaker:

I need to, you know, restore or try and maintain the mechanics of someone's,

Speaker:

you know, joint and their body.

Speaker:

I really want to try and maintain the shape of this for as long as possible.

Speaker:

So the only thing that's left for me

Speaker:

to do is really tell them to not put much weight

Speaker:

on that's probably the best thing that you can tell these patients is to

Speaker:

limit the amount of weight limit the amount of activity that

Speaker:

they do use crutches or a walking aid in order to mitigate that risk of collapse

Speaker:

and then there's other treatments that you can do as well bisphosphonates have

Speaker:

been proposed as um as something that can reduce some of that pain from the

Speaker:

osteonecrosis not sure or if it reduces the risk of collapse though.

Speaker:

And then there's some surgical procedures that have varying levels of evidence

Speaker:

where you decompress this bone and maybe stimulate some healing.

Speaker:

Again, pretty controversial. I have used them in the past when basically I've

Speaker:

got nothing else to offer that patient.

Speaker:

Okay, so that core decompression procedure.

Speaker:

Yeah. Is that true anything on X-ray? Because first we do X-ray. Depending on the stage.

Speaker:

So depending on the stage that you have, but there is a staging system called

Speaker:

FICAT that's commonly, I guess, quoted depending on the stage.

Speaker:

So some, you might have a completely normal x-ray but the MRI is abnormal but

Speaker:

when it proceeds to collapse of the bone and abnormal shape of the bone that

Speaker:

is the time when it shows up on a plain x-ray.

Speaker:

And obviously the arthritis will then show up on a plain x-ray.

Speaker:

So the FICAT stage 3 and 4 will show up on an x-ray if that makes sense.

Speaker:

So this is FAI, so this is.

Speaker:

This is what I'm saying about this being probably some sort of dysmorphism,

Speaker:

but essentially what the patient has is an abnormally shaped proximal femur.

Speaker:

Instead of it being a round ball and a socket, you've got more of an egg-shaped

Speaker:

femoral head, so it stops being round somewhere about here,

Speaker:

and that's essentially how it's diagnosed, by drawing these angles,

Speaker:

which allows you to sort of get this angle about where the femoral head stops

Speaker:

being round. Now you probably don't have to do that.

Speaker:

Radiologists usually do that for us. But it basically gives you an indication

Speaker:

about how severe the FAI is.

Speaker:

But you can imagine if something's not round and this is constantly loading

Speaker:

this area of the hip joint, that's abnormal loading.

Speaker:

It leads to wear and tear of the labrum and then the cartilage and then in this

Speaker:

case, secondary arthritis as well. Okay.

Speaker:

So, how do you assess these patients, all the usual stuff, but specifically

Speaker:

when we're talking about arthritis from a surgical point of view is I want to

Speaker:

know about how severe their pain is.

Speaker:

And I personally use an Oxford hip score, but there's other sort of validated

Speaker:

patient reported measures as well.

Speaker:

It just gives you an overall idea about how much that patient is suffering day

Speaker:

to day with just general sort of activities of daily living.

Speaker:

And then with a younger patient, I want to know a little bit more about what sort of work they do.

Speaker:

So someone who does more manual or physical work and how much the symptoms are impacting on them.

Speaker:

But also, you know, sports and physical activity is going to be very,

Speaker:

very important to these patients.

Speaker:

And again, I want to know about what they do and what's important to them from that point of view.

Speaker:

It's important to know what treatment that they've had so far for their condition.

Speaker:

And I'll see later that that's, I guess, one of the criteria that I use to determine

Speaker:

whether someone should have surgery or not. And of course, their comorbidities.

Speaker:

Examination, look for all the usual stuff, stiffness, irritability, swelling, etc.

Speaker:

And an investigation is usually a plain x-ray, sometimes an MRI.

Speaker:

Okay. So non-surgical treatment. Are you aware of your College of GPs Guidelines

Speaker:

for Management of Arthritis?

Speaker:

I hope you are because they're excellent Basically this is evidence-based approach

Speaker:

To what works best From a non-surgical point of view But first-line therapy.

Speaker:

For arthritis of the hip, knee is these things.

Speaker:

So it's education, basically trying to encourage self-efficacy,

Speaker:

let them take control of their condition, avoid sort of catastrophizing about

Speaker:

the problem, telling them that this is really a normal process a lot of people normally have.

Speaker:

Obviously, in a young patient, maybe not so normal, but arthritis is generally normal.

Speaker:

I tell people that it's a normal part of the human experience to get arthritis

Speaker:

at some point in your life.

Speaker:

So take an active role in their own management and

Speaker:

then land-based exercise and weight

Speaker:

loss so they're the three first line

Speaker:

things so we're not talking about anything else here we're not talking about

Speaker:

injections or fancy you know machines and you know ultrasound therapy and all

Speaker:

of this sort of stuff all of that stuff is like second and third line okay so

Speaker:

often that's not the way we do it.

Speaker:

Often we just like refer people for injections or some sort of interventional treatment.

Speaker:

And it really should be focusing on this first. So I tell people that this is

Speaker:

what they should be focusing on.

Speaker:

And then these things are just trying to, I guess, improve their symptoms a

Speaker:

bit so that they can, again, focus on these things.

Speaker:

Okay. So trying to improve their symptoms with medication or injections or splints

Speaker:

or whatever, to just get them to a happy place so that they can go back to this.

Speaker:

And in terms of surgery, so my criteria for determining whether someone should

Speaker:

have surgery for hip and knee is pretty similar, okay?

Speaker:

So they need to have pain that's significant enough to have a functional impact.

Speaker:

And again, that Oxford score for me is quite helpful because it is quite an

Speaker:

objective way or as objective as possible to get an overall,

Speaker:

I guess, idea about how impacted they are.

Speaker:

But you can imagine in the young patient, it's a different kettle of fish.

Speaker:

So pain for an older patient

Speaker:

who essentially just needs to do some simple day-to-day things like some housework

Speaker:

or walking around the block or going shopping or doing some simple things that

Speaker:

keep them happy is quite different to the 40-year-old who still does CrossFit

Speaker:

and maybe some contact sports.

Speaker:

Okay so that's completely different kettle of fish and when

Speaker:

i say this i'm generalizing but it's very very

Speaker:

much tailored to the individual person and that's

Speaker:

why it's important to understand what their

Speaker:

functional requirements are so right that's part of the history is knowing what

Speaker:

sort of work they do and what sporting activity and all of that sort of stuff

Speaker:

that we inquired about earlier because you want to know about how much they

Speaker:

are impacted by their problem and then you You need some sort of imaging that shows arthritis,

Speaker:

it goes without saying, I think that's a prerequisite.

Speaker:

And then you need to have failure of non-surgical treatment,

Speaker:

so if someone comes to you and they haven't really done anything from a non-surgical

Speaker:

point of view, you need to try and maximize those things first.

Speaker:

Weight-bearing views is what I want, yeah. For a hip, yeah.

Speaker:

I don't think non-weight-bearing x-rays are very useful.

Speaker:

And then I do get specific views later for, you know, once you've decided that

Speaker:

they have surgery, but not to diagnose and for decision-making, right?

Speaker:

So hip preserving procedures just a brief mention

Speaker:

of these i don't want to focus on these too much but hip arthroscopy

Speaker:

is used particularly for fai and it does have some good evidence there's a multi-center

Speaker:

fashion trial that was published in the lancet a few years ago that did show

Speaker:

a benefit over sort of best non-operative treatment so i'd encourage everyone

Speaker:

to at least look at the abstract of that and then you can preserve the hip by

Speaker:

doing these sort of realignment osteotomies.

Speaker:

I don't remember the last time we've done one of those, mostly because hip replacement

Speaker:

and arthroplasty is quite successful.

Speaker:

And you can imagine when you're doing this big procedure like this,

Speaker:

you're preserving the hip, yes, but it's still diseased.

Speaker:

It's still very likely that they'll end up with an arthroplasty at some later stage.

Speaker:

And because arthroplasty has become quite successful, that's probably what we're

Speaker:

focusing on so I'm not going to spend too much time talking about that.

Speaker:

In terms of arthroplasty two main options particularly when we're thinking about

Speaker:

the young patient is a total hip replacement versus a hip resurfacing and this

Speaker:

is what they look like is in the same patient.

Speaker:

Replacement obviously is a removal of a section of the

Speaker:

bone in the proximal femur as well as preparation of

Speaker:

the proximal femur in order to fit a stem whereas a

Speaker:

resurfacing is essentially you're only taking off a

Speaker:

minimal amount of bone and essentially resurfacing the

Speaker:

articulating surfaces i'm not

Speaker:

going to talk too much about total hip replacement because i'm sure that i think

Speaker:

munjid has a talk about it a bit later but most people here would know that

Speaker:

it's a great operation okay like you get headlines like this in the lancet okay

Speaker:

and that's been borne out by amazing outcomes,

Speaker:

patient reported outcomes, satisfaction,

Speaker:

improvement in quality of life,

Speaker:

all very good metrics.

Speaker:

Still by far the most common surgery is a total hip replacement,

Speaker:

97 versus about 3% resurfacing overall.

Speaker:

The problem with a hip replacement, I guess, in a younger patient,

Speaker:

at least in theory, but also some evidence here you can see in the green line,

Speaker:

this is the younger patient group, is because they're younger and more active,

Speaker:

but also younger and more life expectancy, there's going to be a higher revision

Speaker:

rate when it comes to failure of that prosthesis over time.

Speaker:

It's not a huge difference I mean

Speaker:

if you look at the hazard ratios here Which is basically a

Speaker:

comparison Between the younger

Speaker:

group and the older group The long term

Speaker:

hazard ratio is 1.32 Which is a 32% additional risk of revision In that younger

Speaker:

age group But the problem is when it fails It's quite difficult to redo something

Speaker:

like this So if this fails in a significant way,

Speaker:

we're talking about major surgery here and what they're left with after that

Speaker:

sort of revision type hip replacement is never going to be as good as that primary hip replacement.

Speaker:

So that is a real issue for someone who's say in their 40s, you know that at

Speaker:

some point they're likely to have something done.

Speaker:

Not always, but very likely to need something done later on.

Speaker:

Sure. Yeah. But that three months of the revision, I don't quite get it.

Speaker:

That three months, that's a very short time.

Speaker:

Yes. Three months plus. So this data has been divided into hazard ratios for

Speaker:

revision at different time points.

Speaker:

So this represents really, really early complication rates that require revision.

Speaker:

This one sort of represents the medium term. and then more than three months

Speaker:

is sort of the more the longer term right so i focused here on the longer term

Speaker:

hazard ratio of just to make that point of long-term failure but three months,

Speaker:

between two weeks and three months there's actually a

Speaker:

protective effect of being young right and that

Speaker:

sort of makes sense because they're probably less comorbid they're

Speaker:

going to get less infection they're going to you know

Speaker:

be stronger and have less dislocation you know there's lots

Speaker:

of reasons why you can put forward why it's actually better does

Speaker:

that make sense so it's three plus months sorry is

Speaker:

what you're what you might be referring to so it's after

Speaker:

three months sort of more longer term short period i always thought revisions

Speaker:

would happen after a few years it is it is at least so this is at least three

Speaker:

months right but it's eliminating that spike that you get in the early period

Speaker:

in the three months where some people get infections or instability or dislocation,

Speaker:

which often happens in that really, really early period. Yeah?

Speaker:

I'm running out of time so I'm just going to move on because I do want to talk

Speaker:

about hip resurfacing and there is I guess a specific advantage to the younger

Speaker:

patient with hip resurfacing,

Speaker:

if you just look at the prosthesis itself

Speaker:

it preserves the shape and anatomy of the hip okay conserves bone which is really

Speaker:

really important when you're thinking about if there's someone someone needs

Speaker:

a redo procedure later it definitely has better range of motion and there are

Speaker:

studies that show that you get better range of motion with a resurfacing versus a total,

Speaker:

you get faster overall recovery.

Speaker:

So early on it's quite difficult because it is a more invasive surgery versus

Speaker:

a hip replacement, but they recover quicker overall in terms of like,

Speaker:

you know, probably three, six months later, you're getting better functional

Speaker:

outcomes versus a total hip.

Speaker:

And importantly, they get a much higher return to sort of high-level activity, okay?

Speaker:

If you look at the studies, they estimate, you know, about 80% of people can

Speaker:

get to that high level of activity.

Speaker:

And in my mind, what that means is someone who's able to run, essentially, okay?

Speaker:

Like sports that need running, jogging or running, bike riding, etc.

Speaker:

About 80% estimate in a hip resurfacing versus less than 50% for a total hip replacement.

Speaker:

And then you know if it does fail long term

Speaker:

it's relatively easy nobody wants to have a revision don't

Speaker:

get me wrong but it's relatively easy to revise because

Speaker:

you essentially have preserved you know

Speaker:

anatomy and you got a lot of bone left to work

Speaker:

with okay so all we need to do is basically go in

Speaker:

cut this off and then do a stem here

Speaker:

and if that needs revision then it needs to but you

Speaker:

can often just keep the shell if it's stable okay um

Speaker:

very you know famous example you guys

Speaker:

are aware that andy murray had a hip resurfacing he

Speaker:

wanted something done to get him back to that higher level of sport and

Speaker:

he actually did get back and play pretty high level tennis after his

Speaker:

hip resurfacing um i guess

Speaker:

the problem with hip resurfacing is

Speaker:

the metal on metal bearing traditionally it's

Speaker:

been metal on metal and are you guys aware of the

Speaker:

problems with metal on metal it was you know in the

Speaker:

public sphere probably about five or ten years ago where you

Speaker:

do get this thing called metallosis or the wear particles that develop over

Speaker:

over a number of years by these two surfaces articulating can be really really

Speaker:

nasty okay so basically causes this thing called metallosis it is uncommon but

Speaker:

when it does happen it can be quite devastating.

Speaker:

Having said that it's rare and the results of a metal on metal hip resurfacing are very, very good,

Speaker:

but you look at how things have happened you

Speaker:

know how things have progressed again from the registry you

Speaker:

can see that hip resurfacing had a bit of a fad

Speaker:

sort of in the early 2000s then some metal on

Speaker:

metal you know badness happened and now it's like much lower okay so it's you

Speaker:

know around that three percent mark and you can see that there is definitely

Speaker:

a higher overall revision rate when you look at all types of resurfacing versus

Speaker:

a conventional total hip replacement we're still pretty good.

Speaker:

I mean, we're talking at 14% or so over 20 years versus about 11% for a total hip replacement.

Speaker:

So I guess some advances that have happened recently, and I mentioned these

Speaker:

specifically because I'm actually pretty excited about them because I think

Speaker:

they do solve a problem that exists in orthopedics.

Speaker:

And anyone who knows me, okay, you speak to me long enough, I'm very skeptical

Speaker:

about the use of technology in orthopedics, okay?

Speaker:

I actually am very skeptical about robots and computers and how much they actually

Speaker:

add to what we're doing, okay?

Speaker:

It doesn't really, really improve patient outcomes all that much.

Speaker:

It's probably an incremental advance, okay?

Speaker:

I actually think this is more a better advance, okay? These are things that

Speaker:

I'm pretty excited about.

Speaker:

So instead of metal on metal, we've got ceramic. This has literally just been

Speaker:

come out in the last few years.

Speaker:

They needed to get, obviously, the research and the data to support its use,

Speaker:

so we've got I think about 5 years of results now,

Speaker:

excellent results, so very very promising for that sort of more longer term outcomes,

Speaker:

so you can see why, because it just, you know, you don't have that metal on

Speaker:

metal bearing anymore, it's a ceramic bearing and we know that ceramic bearings

Speaker:

don't cause any of that nasty consequence,

Speaker:

okay?

Speaker:

And then the other thing with hip resurfacing is this sort of patient-specific approach.

Speaker:

So essentially the summary of this is that doing a hip resurfacing is much less

Speaker:

forgiving technically.

Speaker:

It's very difficult to get it exactly right.

Speaker:

With a total hip replacement, you've got a lot of leeway. I mean,

Speaker:

we like to be very, very accurate, but you can get it off by like 10, 20 degrees.

Speaker:

And I've seen x-rays where like they look completely wildly off

Speaker:

and the patient still does really really well when things

Speaker:

are put in you know a little bit off right

Speaker:

but hip resurfacing you can't get this very wrong

Speaker:

and the main reason is because you've got this shell and that

Speaker:

shell needs to go on in a very specific way and if

Speaker:

it isn't then you're going to start to get this thing called notching or

Speaker:

you're going to get overloading of one part of the resurfacing and that's

Speaker:

been associated with early failure of this prosthesis so

Speaker:

much less forgiving so the way i think

Speaker:

that this has improved things is it does things specifically for

Speaker:

the patient and you get these scans and you know

Speaker:

it's used in other types of orthopedic surgery as well but with

Speaker:

a resurfacing it allows it to be very very precise so you get this sort of jig

Speaker:

that attaches to their bone and then it allows you to put the wire in exactly

Speaker:

where that patient needs it and then to resurface the bone exactly where that

Speaker:

patient needs it so those two things in combination the ceramic and,

Speaker:

and this patient-specific stuff, I think, is a big advance, especially when

Speaker:

it comes to a younger patient, active, bad arthritis.

Speaker:

I think this is a game-changer in my view.

Speaker:

So, summary, arthritis does affect the young disproportionately when it happens.

Speaker:

In the younger patient, always think of alternate causes.

Speaker:

15% of hip replacement surgery is in the younger patient and hip resurfacing

Speaker:

may be a good option for them.